In-Person Industry Events Ramp Up In Second Half Of 2021
Major European, US And Global Conferences – And Awards – On The Calendar By Year End
Major European, US and international off-patent industry events are switching back to being held in person in the second half of 2021, after a sustained period of largely digital-only interactions.
You may also be interested in...
A whitepaper setting out a comprehensive vision for the off-patent industry to 2030 has been launched by the IGBA. Highlighting the industry’s current contribution to healthcare, it also sets out a path ahead for the generics and biosimilars sector, pointing out headwinds as well as opportunities.
With a looming entry deadline of 30 July, companies have a little under two months to enter the Global Generics & Biosimilars Awards 2021, ahead of the awards ceremony on 10 November.
Advanz Pharma has immediately hit back at a decision announced by the UK’s competition regulator to impose fines of more than £100m over the firm’s historical pricing of liothyronine tablets.